GLP-1 Therapy for Insulin Resistance
Insulin resistance is the metabolic root of weight gain, prediabetes, and PCOS. Physician-prescribed GLP-1 therapy directly addresses the underlying mechanism — not just the symptoms.
No commitment required. Assessment takes about 5 minutes.
What is insulin resistance?
Insulin resistance is a condition in which the body's cells — muscle, fat, and liver — don't respond normally to insulin. The pancreas compensates by producing more insulin, but over time this leads to elevated blood sugar, increased fat storage, and a cascade of metabolic problems.
It is the underlying mechanism behind prediabetes, type 2 diabetes, PCOS, and metabolic syndrome — and it is strongly linked to excess body weight, particularly visceral (abdominal) fat.
How GLP-1 therapy addresses insulin resistance
Enhances Insulin Response
GLP-1 agonists stimulate insulin release in a glucose-dependent manner, improving the body's response to blood sugar.
Promotes Weight Loss
Meaningful weight loss — particularly of visceral fat — is one of the most effective ways to reverse insulin resistance.
Reduces Progression Risk
By improving insulin sensitivity, GLP-1 therapy reduces the risk of progression to prediabetes and type 2 diabetes.